Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMQ8BA6)

Drug Name	Tuberculosis vaccine DMQ8BA6
Synonyms	RBCG30, UCLA; Tuberculosis vaccine, UCLA; Tuberculosis vaccine, University of California LosAngeles; RBCG30, UCLA/Aeras; Subunit TB vaccine, ID Vaccine/Aventis Pasteur; Subunit TB vaccine, ID Vaccine/PMC; TB subunit vaccine, ID Vaccine/Aventis Pasteur; TB subunit vaccine, ID Vaccine/PMC; Tuberculosis vaccine, ID Vaccine/Aventis Pasteur; Tuberculosis vaccine, ID Vaccine/PMC; Tuberculosis vaccine, UCLA/Aeras; Vaccine (TB), ID Vaccine/Aventis Pasteur; Vaccine (TB), ID Vaccine/Pasteur Merieux Connaught; Vaccine (tuberculosis), ID Vaccine/Aventis Pasteur; Vaccine (tuberculosis), ID Vaccine/PMC

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

1 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Tuberculosis	DISZIV9N	1B10-1B1Z	Phase 2	[1]
------------------------------------------------------------------------------------

1 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Mycobacterium infection	DISNSMUD	1B10-1B21	Phase 1	[2]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of Aerus Global TB Vaccine Foundation.
2	New vaccine shows promise as stronger weapon against both tuberculosis and leprosy. Health + Behavior. Enrique Rivero, August 19, 2014.